Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Molecular Brain|March 20, 2020
Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel diseaseYumi Yamamoto, Katsutoshi Kojima, Daisuke Taura, et al.Neuroscience Research|September 25, 2007
Pael receptor is involved in dopamine metabolism in the nigrostriatal systemYuzuru Imai, Haruhisa Inoue, Ayane Kataoka, et al.Scientific Reports|October 11, 2016
Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neuronsKeiko Imamura, Naruhiko Sahara, Nicholas M Kanaan, et al.Scientific Reports|May 14, 2022
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2Naohiro Egawa, Yuishin Izumi, Hidefumi Suzuki, et al.JCI Insight|April 22, 2024
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunctionYuki Otsuka, Keiko Imamura, Akio Oishi, et al.NPJ Vaccines|March 29, 2020
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model miceHiroki Takeuchi, Keiko Imamura, Bin Ji, et al.Clinical Science (London, England : 1979)|February 20, 2019
MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neuronsFumiko Nakazeki, Itaru Tsuge, Takahiro Horie, et al.Science Translational Medicine|May 26, 2017
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosisKeiko Imamura, Yuishin Izumi, Akira Watanabe, et al.Science Translational Medicine|June 7, 2013
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.Science Translational Medicine|August 3, 2012
Drug screening for ALS using patient-specific induced pluripotent stem cellsNaohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.Pageof 5